Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials.

Syst Rev · 2025 · PMC11786358 · PMID 39893467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Several meta-analyses have shown a reduction in ventricular tachycardia following SGLT2 inhibitor treatment, although these findings did not reach statistical significance [ 11 – 14 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.